166 related articles for article (PubMed ID: 32163508)
21. Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study.
Stevens M; Rusch S; DeVincenzo J; Kim YI; Harrison L; Meals EA; Boyers A; Fok-Seang J; Huntjens D; Lounis N; Mari N K; Remmerie B; Roymans D; Koul A; Verloes R
J Infect Dis; 2018 Jul; 218(5):748-756. PubMed ID: 29684148
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory Effect of
Chathuranga K; Weerawardhana A; Dodantenna N; Ranathunga L; Cho WK; Ma JY; Lee JS
Viruses; 2021 Mar; 13(4):. PubMed ID: 33806073
[No Abstract] [Full Text] [Related]
23. Supplementing a Saccharomyces cerevisiae fermentation product modulates innate immune function and ameliorates bovine respiratory syncytial virus infection in neonatal calves.
Mahmoud AHA; Slate JR; Hong S; Yoon I; McGill JL
J Anim Sci; 2020 Aug; 98(8):. PubMed ID: 32780814
[TBL] [Abstract][Full Text] [Related]
24. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.
McGill JL; Kelly SM; Kumar P; Speckhart S; Haughney SL; Henningson J; Narasimhan B; Sacco RE
Sci Rep; 2018 Feb; 8(1):3021. PubMed ID: 29445124
[TBL] [Abstract][Full Text] [Related]
26. Thiol-Activated Hydrogen Sulfide Donors Antiviral and Anti-Inflammatory Activity in Respiratory Syncytial Virus Infection.
Bazhanov N; Ivanciuc T; Wu H; Garofalo M; Kang J; Xian M; Casola A
Viruses; 2018 May; 10(5):. PubMed ID: 29747463
[TBL] [Abstract][Full Text] [Related]
27. Antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection.
Chen LF; Zhong YL; Luo D; Liu Z; Tang W; Cheng W; Xiong S; Li YL; Li MM
J Ethnopharmacol; 2019 Oct; 242():111575. PubMed ID: 30391397
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection.
Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
[TBL] [Abstract][Full Text] [Related]
30. A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection.
Nilsson AC; Pullman J; Napora P; Luz K; Gupta A; Draghi J; Guzman Romero AK; Aggarwal N; Petrova G; Ianus J; Vijgen L; Scott J; Sinha R; Rusch S; Huntjens D; Bertzos K; Stevens M;
Clin Microbiol Infect; 2023 Oct; 29(10):1320-1327. PubMed ID: 37422079
[TBL] [Abstract][Full Text] [Related]
31. Bovine respiratory syncytial virus in experimentally exposed and rechallenged calves; viral shedding related to clinical signs and the potential for transmission.
Klem TB; Sjurseth SK; Sviland S; Gjerset B; Myrmel M; Stokstad M
BMC Vet Res; 2019 May; 15(1):156. PubMed ID: 31109324
[TBL] [Abstract][Full Text] [Related]
32. Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus.
Thomas LH; Cook RS; Wyld SG; Furze JM; Taylor G
J Infect Dis; 1998 Apr; 177(4):874-80. PubMed ID: 9534958
[TBL] [Abstract][Full Text] [Related]
33. Immunology of bovine respiratory syncytial virus in calves.
Guzman E; Taylor G
Mol Immunol; 2015 Jul; 66(1):48-56. PubMed ID: 25553595
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
[TBL] [Abstract][Full Text] [Related]
35. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
[TBL] [Abstract][Full Text] [Related]
36. Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans.
Patel K; Kirkpatrick CM; Nieforth KA; Chanda S; Zhang Q; McClure M; Fry J; Symons JA; Blatt LM; Beigelman L; DeVincenzo JP; Huntjens DR; Smith PF
J Antimicrob Chemother; 2019 Feb; 74(2):442-452. PubMed ID: 30376079
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant.
Gottlieb J; Torres F; Haddad T; Dhillon G; Dilling DF; Knoop C; Rampolla R; Walia R; Ahya V; Kessler R; Budev M; Neurohr C; Glanville AR; Jordan R; Porter D; McKevitt M; German P; Guo Y; Chien JW; Watkins TR; Zamora MR
J Heart Lung Transplant; 2023 Jul; 42(7):908-916. PubMed ID: 36964084
[TBL] [Abstract][Full Text] [Related]
38. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
[TBL] [Abstract][Full Text] [Related]
39. Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs.
Larios Mora A; Detalle L; Gallup JM; Van Geelen A; Stohr T; Duprez L; Ackermann MR
MAbs; 2018 Jul; 10(5):778-795. PubMed ID: 29733750
[TBL] [Abstract][Full Text] [Related]
40. The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.
Kim YI; Pareek R; Murphy R; Harrison L; Farrell E; Cook R; DeVincenzo J
Influenza Other Respir Viruses; 2017 Nov; 11(6):525-530. PubMed ID: 28990339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
